Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 6 | |
Outperform | 6 | |
Hold | 3 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 14 analysts offering 12 month price targets for Travere Therapeutics Inc have a median target of 18.00, with a high estimate of 25.00 and a low estimate of 9.00. The median estimate represents a 25.44% increase from the last price of 14.35.
High | 74.2% | 25.00 |
Med | 25.4% | 18.00 |
Low | -37.3% | 9.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate | -0.43% |
Average growth rate | -5.37% |
More ▼
Revenue history & estimates in USD
Average growth rate | +1.56% |
Average growth rate | -2.62% |
More ▼